IFN-γ and CD38 in Hyperprogressive Cancer Development

IFN-γ and CD38 in Hyperprogressive Cancer Development

Immune checkpoint inhibitors (ICIs) improve the survival of patients with multiple types of cancer. However, low response rates and atypical responses limit their success in clinical applications. The paradoxical acceleration of tumor growth after treatment, defined as hyperprogressive disease (HPD)...

Full description

Bibliographic Details
Main Authors: Stefania Angelicola, Francesca Ruzzi, Lorena Landuzzi, Laura Scalambra, Francesco Gelsomino, Andrea Ardizzoni, Patrizia Nanni, Pier-Luigi Lollini, Arianna Palladini
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Cancers
Subjects:
hyperprogression
hyperprogressive disease
cancer
immune checkpoint inhibitors
immunotherapy
IFN-γ
Online Access:https://www.mdpi.com/2072-6694/13/2/309

Internet

https://www.mdpi.com/2072-6694/13/2/309

Similar Items